Single User License
INR 170050
Site License
INR 340100
Corporate User License
INR 510150

Service Tax Additional

select a format
Price

Single User License
USD 2500
Site License
USD 5000
Corporate User License
USD 7500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Thrombocytopenia Global Clinical Trials Review, H1

Thrombocytopenia Global Clinical Trials Review, H1


  Request for Sample Report

Executive Summary

Thrombocytopenia Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Thrombocytopenia Global Clinical Trials Review, H1, 2015" provides an overview of Thrombocytopenia clinical trials scenario. This report provides top line data relating to the clinical trials on Thrombocytopenia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global clinical trials landscape

Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

The Report provides enrollment trends for the past five years

Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons To Buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Thrombocytopenia 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Thrombocytopenia to Hematological Disorders Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Thrombocytopenia to Hematological Disorders Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Thrombocytopenia 25

Subjects Recruited Over a Period of Time 30

Clinical Trials by Sponsor Type 31

Prominent Sponsors 32

Top Companies Participating in Thrombocytopenia Therapeutics Clinical Trials 33

Prominent Drugs 34

Latest Clinical Trials News on Thrombocytopenia 35

Jun 12, 2015: FDA Approves Promacta for New Pediatric Chronic Immune Thrombocytopenia (cITP) Indication 35

Jun 10, 2015: CTI BioPharma And Baxter Announce Patient-Reported Outcomes (PROs) From Pacritinib Phase 3 In Patients With Myelofibrosis To Be Presented In Late-Breaking Session At EHA 35

May 27, 2015: Amgen To present data from Nplate study at the 20th Congress of the EHA 36

Clinical Trial Profiles 37

Clinical Trial Overview of Top Companies 37

GlaxoSmithKline Plc 37

Clinical Trial Overview of GlaxoSmithKline Plc 37

Amgen Inc. 42

Clinical Trial Overview of Amgen Inc. 42

Eisai Co., Ltd. 45

Clinical Trial Overview of Eisai Co., Ltd. 45

F. Hoffmann-La Roche Ltd. 47

Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 47

Shionogi & Co., Ltd. 48

Clinical Trial Overview of Shionogi & Co., Ltd. 48

Pfizer Inc. 49

Clinical Trial Overview of Pfizer Inc. 49

Octapharma AG 50

Clinical Trial Overview of Octapharma AG 50

Baxter International Inc. 51

Clinical Trial Overview of Baxter International Inc. 51

Rigel Pharmaceuticals, Inc. 52

Clinical Trial Overview of Rigel Pharmaceuticals, Inc. 52

Biogen, Inc. 53

Clinical Trial Overview of Biogen, Inc. 53

Clinical Trial Overview of Top Institutes / Government 54

Shandong University 54

Clinical Trial Overview of Shandong University 54

Weill Cornell Medical College 56

Clinical Trial Overview of Weill Cornell Medical College 56

Henri Mondor University Hospital 57

Clinical Trial Overview of Henri Mondor University Hospital 57

National Heart, Lung, and Blood Institute 58

Clinical Trial Overview of National Heart, Lung, and Blood Institute 58

University of California, San Francisco 59

Clinical Trial Overview of University of California, San Francisco 59

Assistance Publique-Hopitaux de Paris 60

Clinical Trial Overview of Assistance Publique-Hopitaux de Paris 60

Boston Children's Hospital 61

Clinical Trial Overview of Boston Children's Hospital 61

Hospital Universitario "Dr. Jose E. Gonzalez" 62

Clinical Trial Overview of Hospital Universitario "Dr. Jose E. Gonzalez" 62

New England Research Institutes 63

Clinical Trial Overview of New England Research Institutes 63

Peking University People's Hospital 64

Clinical Trial Overview of Peking University People's Hospital 64

Five Key Clinical Profiles 65

Appendix 107

Abbreviations 107

Definitions 107

Research Methodology 108

Secondary Research 108

About GlobalData 109

Contact Us 109

Disclaimer 109

Source 110

List of Figures

Thrombocytopenia Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Thrombocytopenia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Thrombocytopenia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Thrombocytopenia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Thrombocytopenia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Thrombocytopenia Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Thrombocytopenia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13

Thrombocytopenia Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14

Proportion of Thrombocytopenia to Hematological Disorders Clinical Trials, G7 Countries (%), 2015* 15

Thrombocytopenia Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Thrombocytopenia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Thrombocytopenia to Hematological Disorders Clinical Trials, E7 Countries (%), 2015* 18

Thrombocytopenia Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Thrombocytopenia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Thrombocytopenia Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Thrombocytopenia Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Thrombocytopenia Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Thrombocytopenia Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Thrombocytopenia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 30

Thrombocytopenia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 31

Thrombocytopenia Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 32

Thrombocytopenia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 33

Thrombocytopenia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 34

GlobalData Methodology 108

List of Tables

Thrombocytopenia Therapeutics, Global, Clinical Trials by Region, 2015* 7

Thrombocytopenia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Thrombocytopenia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Thrombocytopenia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Thrombocytopenia Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Thrombocytopenia Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Thrombocytopenia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13

Thrombocytopenia Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14

Proportion of Thrombocytopenia to Hematological Disorders Clinical Trials, G7 Countries (%), 2015* 15

Thrombocytopenia Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Thrombocytopenia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Thrombocytopenia to Hematological Disorders Clinical Trials, E7 Countries (%), 2015* 18

Thrombocytopenia Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Thrombocytopenia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Thrombocytopenia Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Thrombocytopenia Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Thrombocytopenia Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Thrombocytopenia Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Thrombocytopenia Therapeutics, Global, Suspended Clinical Trials, 2015* 25

Thrombocytopenia Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26

Thrombocytopenia Therapeutics, Global, Terminated Clinical Trials, 2015* 27

Thrombocytopenia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 30

Thrombocytopenia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 31

Thrombocytopenia Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 32

Thrombocytopenia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 33

Thrombocytopenia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 34

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline Plc, 2015* 37

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2015* 42

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2015* 45

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 47

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Shionogi & Co., Ltd., 2015* 48

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 49

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Octapharma AG, 2015* 50

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Baxter International Inc., 2015* 51

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Rigel Pharmaceuticals, Inc., 2015* 52

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Biogen, Inc., 2015* 53

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Shandong University, 2015* 54

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Weill Cornell Medical College, 2015* 56

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Henri Mondor University Hospital, 2015* 57

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2015* 58

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2015* 59

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique-Hopitaux de Paris, 2015* 60

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston Children's Hospital, 2015* 61

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Universitario "Dr. Jose E. Gonzalez", 2015* 62

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by New England Research Institutes, 2015* 63

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Peking University People's Hospital, 2015* 64

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

GlaxoSmithKline Plc

Amgen Inc.

Eisai Co., Ltd.

F. Hoffmann-La Roche Ltd.

Shionogi & Co., Ltd.

Pfizer Inc.

Octapharma AG

Baxter International Inc.

Rigel Pharmaceuticals, Inc.

Biogen, Inc.

Thrombocytopenia Clinical Trials, Phase, Completed, Ongoing, Planned, End Points, Trial Locations, Trial Designs, Subjects Recruited, Safety, Efficacy, Bioequivalence, Pharmacokinetics, Pharmacodynamic, Sponsor, Collaborator, CRO's, Terminated, Suspended and Withdrawn trials of Thrombocytopenia, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas M. D. Anderson Cancer Center, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, University of Pennsylvania.


Related Products in vertical
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com